Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil

Clinical trial NCT01845636 · COMPLETED

Trial details

NCT number: NCT01845636
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Mild Cognitive Impairment

Start date: 2012-08-01
Primary completion: 2016-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.